ReviewAntibiotics (Basel, Switzerland)2026
Ceftazidime-Avibactam as Early Empiric Therapy for Gram-Negative Nosocomial Infections: A Risk-Stratified Empiric Use Informed by National AMR Surveillance Data 2024.
Ahmad Subhi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.